For research use only. Not for therapeutic Use.
Carlumab (CNTO 888) is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer[1].
| Catalog Number | I043201 |
| CAS Number | 915404-94-3 |
| Purity | ≥95% |
| Reference | [1]. Fetterly GJ, et al.. Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data. J Clin Pharmacol. 2013 Oct;53(10):1020-7. |
